According to Statifacts, the global clinical trials market size is calculated at USD 126.30 billion in 2025 and is expected ...

The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or ...

For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Sedana Medical AB (publ) announces that its second pivotal US trial INSPiRE-ICU 2 has met its primary endpoint, and hence established non-inferiority of inhaled sedation with isoflurane compared with ...

CHICAGO - Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group with a market capitalization of $15.11 million, is ...

CEO Jim Frakes noted that Aethlon Medical has made significant progress in focusing on oncology and implementing cost reductions. Operating expenses were reduced by 50% compared to the same quarter ...

Frost & Sullivan recently analyzed the biotechnology contract research organization (CRO) industry and, based on its findings ...

A Manchester medtech company has secured new funding to continue scaling its reusable digital device that can track whether ...

Yaqrit acquired full global rights, including development and commercial, for OPA in any indication from Mallinckrodt Pharmaceuticals in the second half of 2024. Mallinckrodt Pharmaceuticals will ...

After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...

Q3 2025 Earnings Call Transcript February 12, 2025 Aethlon Medical, Inc. beats earnings expectations. Reported EPS is $-0.13, ...